Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromas

Brigitte C. Widemann, Wanda L. Salzer, Robert J. Arceci, Susan M. Blaney, Elizabeth Fox, David End, Andrea Gillespie, Patricia Whitcomb, Joseph S. Palumbo, Aaron Pitney, Nalini Jayaprakash, Peter Zannikos, Frank M. Balis

Research output: Contribution to journal › Article › peer-review

109 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromas'. Together they form a unique fingerprint.

Medicine & Life Sciences